Surrozen, Inc./DE Proceeds from Related Party Debt
Surrozen, Inc./DE (SRZN) reported Proceeds from Related Party Debt of $147.75 thousand for the 4-month period ending 2020-12-31, per its 10-K/A filed 2021-05-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRelatedPartyDebt · last filed 2021-05-14
- 2020-12-31: Proceeds from Related Party Debt 4 month $147.75K.
- 2020-09-30: Proceeds from Related Party Debt 1 month $650.00.
| Period end | Proceeds from Related Party Debt 1 month | Proceeds from Related Party Debt 4 month |
|---|---|---|
| 2020-12-31 | $147.75K 10-K/A · filed 2021-05-14 | |
| 2020-09-30 | $650.00 10-Q/A · filed 2021-01-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |